Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (441-450 of 467) with videos related to

Pageof 47
Sort By:
Journal of Neuro-Oncology|August 5, 2025
The concept, intention, and evaluation of the term treatment-refractory meningiomaLasse Rehné Jensen, Andrea Daniela Maier, Tareq A Juratli, et al.
Cancers|July 24, 2021
Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23Peter Hau, Didier Frappaz, Elizabeth Hovey, et al.
Nature|November 5, 2015
Brain tumour cells interconnect to a functional and resistant networkMatthias Osswald, Erik Jung, Felix Sahm, et al.
Neuro-Oncology|July 18, 2022
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trialAndrew B Lassman, Stephanie L Pugh, Tony J C Wang, et al.
The Lancet. Oncology|October 3, 2024
A brave new framework for glioma drug developmentKelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Neuro-Oncology|February 14, 2022
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effortEmilie Le Rhun, Patrick Devos, Sebastian Winklhofer, et al.
ESMO Open|March 4, 2017
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)Gilberto Morgan, Matteo Lambertini, Hampig Raphael Kourie, et al.
The Lancet. Oncology|July 31, 2025
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomasNorbert Galldiks, Philipp Lohmann, Mariam Aboian, et al.
Neuro-Oncology Advances|November 29, 2023
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphomaKarl-Heinz Nenning, Johanna Gesperger, Julia Furtner, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2023
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419)Caroline Hertler, Jörg Felsberg, Dorothee Gramatzki, et al.
Pageof 47

Showing results (441-450 of 467) with videos related to

Sort By:
Pageof 47
Journal of Neuro-Oncology|August 5, 2025
The concept, intention, and evaluation of the term treatment-refractory meningiomaLasse Rehné Jensen, Andrea Daniela Maier, Tareq A Juratli, et al.
Cancers|July 24, 2021
Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23Peter Hau, Didier Frappaz, Elizabeth Hovey, et al.
Nature|November 5, 2015
Brain tumour cells interconnect to a functional and resistant networkMatthias Osswald, Erik Jung, Felix Sahm, et al.
Neuro-Oncology|July 18, 2022
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trialAndrew B Lassman, Stephanie L Pugh, Tony J C Wang, et al.
The Lancet. Oncology|October 3, 2024
A brave new framework for glioma drug developmentKelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Neuro-Oncology|February 14, 2022
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effortEmilie Le Rhun, Patrick Devos, Sebastian Winklhofer, et al.
ESMO Open|March 4, 2017
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)Gilberto Morgan, Matteo Lambertini, Hampig Raphael Kourie, et al.
The Lancet. Oncology|July 31, 2025
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomasNorbert Galldiks, Philipp Lohmann, Mariam Aboian, et al.
Neuro-Oncology Advances|November 29, 2023
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphomaKarl-Heinz Nenning, Johanna Gesperger, Julia Furtner, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2023
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419)Caroline Hertler, Jörg Felsberg, Dorothee Gramatzki, et al.
Pageof 47